Breaking news
Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing
Sen. Bernie Sanders, left, appears at a news conference with Sen. Ed Markey on issuing subpoenas for pharmaceutical company CEOs to testify regarding drug prices, in the Capitol, Jan. 25, 2024. Bill Clark | Cq-roll Call, Inc. | Getty Images Senators will question the CEOs of Johnson & Johnson, Merck and Bristol Myers Squibb on […]
Read More
SoftBank nets $16 billion on Arm earnings pop, exceeding its complete losses in WeWork
Billionaire Masayoshi Son, chairman and main executive officer of SoftBank, which owns Arm, speaks for the duration of a information meeting in Tokyo, July 28, 2016. Tomohiro Ohsumi | Bloomberg | Getty Images Masayoshi Son’s SoftBank built much more in Arm’s following-hrs buying and selling on Wednesday than the total amount of money the business […]
Read More
Inexperienced Plains inventory jumps immediately after enterprise announces strategic overview, standstill with Ancora
Ethanol plant in Milton, Wisconsin. Getty Pictures Ethanol producer and agri-tech firm Eco-friendly Plains stated Wednesday that it would initiate a strategic evaluation, a calendar year just after activist investor Ancora sent a letter to its board encouraging it to do just that. Shares jumped a lot more than 15% in midday buying and selling […]
Read More
Roblox shares rise 16% following company beats estimates and problems robust steerage
David Baszucki, main government officer and co-founder of Roblox Corp., speaks all through a Bloomberg Studio 1. tv job interview in San Francisco, California, on Thursday, April, 21, 2022. David Paul Morris | Bloomberg | Getty Pictures Roblox described outcomes for the fiscal fourth quarter on Wednesday that beat consensus estimates on the top and […]
Read More
CVS beats estimates, but cuts full-year profit outlook on higher medical costs
A CVS location in New York, US, on Thursday, Feb. 9, 2023. Stephanie Keith | Bloomberg | Getty Images CVS Health on Wednesday reported fourth-quarter revenue and adjusted earnings that topped expectations, but the company cut its full-year profit outlook, citing higher medical costs that are dogging the broader insurance industry. The company lowered its […]
Read More
Ukraine war reside updates: Tucker Carlson teases interview with Vladimir Putin Russia launches missiles strikes on significant metropolitan areas
Russia launches missile assault on Ukrainian towns, officials say Russia launched many waves of missile strikes on Kyiv and other Ukrainian towns through Wednesday morning rush several hours, Ukrainian officers reported, with slipping debris from the downed weapons chopping off electric power to sections of the money. Quite a few waves of blasts rocked Kyiv […]
Read More
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. Brendan McDermid | Reuters Eli Lilly on Tuesday said its highly popular drug used for weight loss and diabetes showed promise as a treatment for fatty liver disease in a midstage trial. The initial study […]
Read More
Adam Neumann is striving to invest in bankrupt WeWork, DealBook reports
Adam Neumann, Founder and former CEO of WeWork. Eduardo Munoz | Reuters Billionaire Adam Neumann is attempting to get back again bankrupt true-estate organization WeWork, which he launched in 2010 and was ousted from in 2019, DealBook noted Tuesday. Neumann, his startup Stream and Dan Loeb’s Third Position fund have “regularly expressed” a “honest curiosity” […]
Read More
Eli Lilly results blow past estimates on strong Zepbound launch, surging Mounjaro revenue
Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020. Mike Blake | Reuters Eli Lilly on Tuesday reported fourth-quarter revenue and adjusted earnings that topped expectations on the strong launch of its new weight loss drug, Zepbound, and higher prices for its blockbuster diabetes drug, Mounjaro. […]
Read More
UBS beats earnings expectations, announces up to $1 billion share buyback
Fabrice Coffrini | Afp | Getty Illustrations or photos Swiss banking large UBS on Tuesday narrowly beat fourth-quarter earnings anticipations and introduced that it would recommence share buybacks value up to $1 billion in the 2nd 50 % of the calendar year. The team posted a net decline attributable to shareholders of $279 million for […]
Read More